Click here for links to all Expanded Tables of Contents
EXPANDED TABLE OF CONTENTS
VOLUME 5, NUMBER 3 MARCH 2002
TREATMENT HIGHLIGHTS
NICOTINE DEPENDENCE
Adolescent perception of parental disapproval of cigarette smoking is associated with a lower likelihood of adolescent smoking.

ALCOHOL USE DISORDERS
Naltrexone (Depade, ReVia) at a dose of 50 mg/day is not found to be effective in the treatment of chronic, severe alcohol dependence among male veterans.

STIFF-PERSON SYNDROME
Intravenous immune globulin is found to be an effective treatment for stiff-person syndrome.

STALKING
Female stalkers are found to differ from male stalkers in their motivation for stalking and in their choice of victim.

EMPLOYMENT AND THE SEVERELY MENTALLY ILL
The Individual Placement and Support program is found to be effective in helping patients with severe mental illness obtain work. Job retention, however, is “problematic.”

OF NOTE
Youths who participate in team sports are found to have lower rates of tobacco, alcohol, and illicit drug use, compared to youths who do not participate in team sports.

Trends in the outpatient treatment of depressive disorders in the United States are found to have changed over a 10-year period. Key findings from 2 national surveys are presented.

“Alcohol is the number one drug of choice among America’s teens and underage drinking is a problem of epidemic proportion,” according to a recent report by the National Center on Addiction and Substance Abuse at Columbia University (CASA).

PSYCHOPHARMACOLOGY NOTE
Patients with bipolar disorder (mixed or manic episode) who have not adequately responded to valproate (eg, Depakote) or lithium (eg, Eskalith) may experience symptom improvement when olanzapine (Zyprexa) is added.

FDA NEWS AND REVIEW
Product Safety Information: Changes have been made in the labeling for Ritalin and Ritalin SR (methylphenidate). Added is a precaution about using methylphenidate in combination with clonidine (serious adverse events have been reported). Also added is text stating that methylphenidate is contraindicated during treatment with monoamine oxidase inhibitors.

ASSESSMENT
Smoking Effects Questionnaire (SEQ)

RESOURCES
Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials.